LifeStance Health Group, Inc. (LFST) Earnings History
Profitable7 years of earnings data (2019–2025) · Positive TTM net income
Loading earnings history...
LifeStance Health Group, Inc. (LFST) Earnings Overview
As of October 3, 2026, LifeStance Health Group, Inc. (LFST) reported trailing twelve-month net income of $51M, reflecting +113.3% year-over-year growth. The company earned $0.13 per diluted share over the past four quarters, with a net profit margin of 0.7%.
Looking at the long-term picture, LFST's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2025, representing a new all-time high.
LifeStance Health Group, Inc. maintains positive profitability with a gross margin of 32.4%, operating margin of 1.7%, and net margin of 0.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ACHC (-$1.13B net income, -33.3% margin), UHS ($1.53B net income, 8.6% margin), SGRY (-$89M net income, -2.4% margin), LFST has outperformed on profitability metrics. Compare LFST vs ACHC →
LFST Earnings vs Peers
Earnings metrics vs comparable public companies
LFST Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10M | +116.8% | $24M | $0.02 | 0.7% | 1.7% |
| 2024 | -$57M | +69.2% | -$32M | $-0.15 | -4.6% | -2.5% |
| 2023 | -$186M | +13.6% | -$189M | $-0.51 | -17.6% | -17.9% |
| 2022 | -$216M | +29.8% | -$210M | $-0.61 | -25.1% | -24.5% |
| 2021 | -$307M | -706.9% | -$286M | $-1.05 | -46.0% | -42.9% |
| 2020 | -$38M | -771.5% | $15M | $-0.83 | -10.1% | 4.1% |
| 2019 | $6M | - | $15M | $-0.16 | 2.7% | 7.2% |
Download Data
Export LFST earnings history in CSV or JSON format
Free sign-in required to download data
LFST Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LFST — Frequently Asked Questions
Quick answers to the most common questions about buying LFST stock.
What is LFST earnings per share (EPS)?
LFST trailing twelve-month (TTM) diluted EPS is $0.13, reflecting +113.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is LifeStance Health Group, Inc.'s net income?
LifeStance Health Group, Inc. (LFST) trailing twelve-month net income is $51M as of 2025. Earnings grew +113.3% year-over-year.
Is LFST profitable?
Yes, LFST is profitable with a TTM net income of $51M and a net profit margin of +0.7%.
What is LFST's earnings growth rate?
LFST compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are LFST's profit margins?
LifeStance Health Group, Inc. net profit margin is +0.7%, operating margin is +1.7%, and gross margin is +32.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is +0.7%.
Is LFST growing earnings?
Yes, LFST earnings are accelerating — EPS growth of +113.3% exceeds the 5-year CAGR of N/A. TTM net income reached $51M. Earnings momentum is strengthening.
What was LFST's best earnings year?
LifeStance Health Group, Inc.'s highest annual net income on record is $10M, achieved in fiscal year 2025. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were LFST's earnings last quarter?
LFST's most recent reported quarter was Q2 2026. Net income was $24M with diluted EPS of $0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.